X-linked hereditary motor sensory neuropathy (type 1) presenting with a stroke-like episode

Developmental Medicine and Child Neurology

Volumn 52, Issue 7, 2010, Pages 677-679

  Anand, Geetha ^a   Maheshwari, Nitin ^a   Roberts, David ^a   Padeniya, Anuruddha ^a   Hamilton Ayers, Michele ^b   Van Der Knaap, Marjo ^c   Fratter, Carl ^d   Jayawant, Sandeep ^a  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b CHELTENHAM GENERAL HOSPITAL   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; AMINO ACID SUBSTITUTION; ARTICLE; BRAIN EDEMA; CASE REPORT; CHILD; DIFFERENTIAL DIAGNOSIS; DYSPHASIA; GENE MUTATION; GENETIC ANALYSIS; HEMIPARESIS; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; LEUKODYSTROPHY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; SCHOOL CHILD; STROKE; X LINKED HEREDITARY MOTOR SENSORY NEUROPATHY TYPE 1;

BRAIN; CHARCOT-MARIE-TOOTH DISEASE; CHILD; CONNEXINS; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC DISEASES, X-LINKED; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUTATION, MISSENSE; STROKE;

EID: 77954644216     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2010.03674.x     Document Type: Article

References (11)

1. Shy ME, Blake J, Krajewski K. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005, 64:1209-14.
2. Paulson HL, Garbern JY, Hoban TF. Transient central nervous system white matter abnormality in X linked Charcot-Marie-Tooth disease. Ann Neurol 2002, 52:429-34.
3. Schelhaas HJ, Van Engelen BG, Gabreels-Festen AA. Transient cerebral white matter lesions in a patient with connexin 32 missense mutation. Neurology 2002, 59:2007-8.
4. Hanemann CO, Bergmann C, Senderek J. Transient, recurrent white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexion 32 mutation. Arch Neurol 2003, 60:605-9.
5. Taylor RA, Simon EM, Marks HG. The CNS phenotype of X-linked Charcot-Marie-Tooth disease: more than a peripheral problem. Neurology 2003, 61:1475-8.
6. Isoardo G, Di VitoN, Nobile M. X-linked Charcot-Marie-Tooth disease and progressive-relapsing central demyelinating disease. Neurology 2005, 65:1672-3.
7. Siskind C, Feely SM, Bernes S, Shy ME, Garbern JY. Persistent CNS dysfunction in a boy with CMT1X. J Neurol Sci 2009, 279:109-13.
8. Basri R, Yabe I, Soma H, Matsushima M, Tsuji S, Sasaki H. X-linked Charcot-Marie-Tooth disease (CMTX) in a severely affected female patient with scattered lesions in cerebral white matter. Intern Med 2007, 46:1023-7.
9. Sargiannidou I, Vavlitou N, Aristodemou S. Connexin 32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects. J Neurosci 2009, 29:4736-49.
10. Ikegami T. Four novel mutations of the connexin 32 gene in four Japanese families with Charcot-Marie-Tooth disease Type 1. Am J Med Genet 1998, 80:352-5.
11. Williams MM. HMSN and HNPP. Laboratory service provision in the south west of England-two years' experience. Ann N Y Acad Sci 1999, 883:500-3.